TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $28,098 | +5.6% | 1,705 | 0.0% | 0.00% | – |
Q4 2022 | $26,598 | -14.2% | 1,705 | -27.7% | 0.00% | – |
Q3 2022 | $31,000 | -6.1% | 2,359 | 0.0% | 0.00% | – |
Q2 2022 | $33,000 | -2.9% | 2,359 | 0.0% | 0.00% | – |
Q1 2022 | $34,000 | +6.2% | 2,359 | 0.0% | 0.00% | – |
Q4 2021 | $32,000 | -17.9% | 2,359 | 0.0% | 0.00% | – |
Q3 2021 | $39,000 | -2.5% | 2,359 | 0.0% | 0.00% | – |
Q2 2021 | $40,000 | -14.9% | 2,359 | -8.7% | 0.00% | – |
Q1 2021 | $47,000 | -13.0% | 2,585 | -12.4% | 0.00% | – |
Q4 2020 | $54,000 | -36.5% | 2,951 | -37.7% | 0.00% | – |
Q3 2020 | $85,000 | +9.0% | 4,740 | +8.4% | 0.00% | – |
Q2 2020 | $78,000 | -29.1% | 4,374 | -39.9% | 0.00% | – |
Q1 2020 | $110,000 | -98.0% | 7,279 | -97.4% | 0.00% | -100.0% |
Q4 2019 | $5,476,000 | +1075.1% | 277,809 | +919.4% | 0.00% | – |
Q3 2019 | $466,000 | -57.6% | 27,253 | -56.2% | 0.00% | -100.0% |
Q2 2019 | $1,098,000 | -77.7% | 62,250 | -74.3% | 0.00% | -66.7% |
Q1 2019 | $4,924,000 | – | 241,934 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |